CCMC

Name: Marilyn Li
Title: Director, Cancer Genetics Laboratory, Baylor College of Medicine

Oxford Gene Technology said this week that it has signed an agreement with the Cancer Cytogenomics Microarray Consortium to use the organization's suggested cancer array design to develop and launch its own whole-genome, cancer-specific chip.

NEW YORK (GenomeWeb News) – Oxford Gene Technology said today it signed a license agreement with the Cancer Cytogenomics Microarray Consortium to create a whole genome, cancer-specific microarray.

While adoption of arrays for clinical testing is still in its early stages, some members of the Cancer Cytogenomics Microarray Consortium at their annual meeting in Chicago last week praised an ongoing dialogue between the CCMC and array vendors, and stated that they hope that th

Name: Anwar Iqbal
Title: Director of microarray CGH laboratory, department of pathology, University of Rochester Medical Center

Brynn Levy has been elected president of the Cancer Cytogenomics Microarray Consortium. Levy, who is director of clinical cytogenetics at Columbia University Medical Center, will take the reins of the organization from current president Anwar Iqbal next year.

CHICAGO — Cancer Genetics will later this year expand its menu of array-based tests to include assays for informing treatment of patients with diffuse large B-cell lymphoma and renal cell carcinoma.

Officials from BlueGnome and the CCMC said they hope the wider availability of the arrays will spur cancer cytogenetics researchers to adopt the consortium's design and further the efforts of the CCMC to set standards for using arrays in cytogenetics.

The CCMC will next year carry out a multicenter validation study to demonstrate that the technology is reliable and reproducible enough for clinical use.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.